How Chronic Infections Accelerate Aging

One pattern I keep seeing in clinic: patients in their 50s or 60s who feel a decade older than they should — persistent fatigue, brain fog, joints that ache without explanation, an immune system that seems sluggish. Their standard labs are unremarkable. But when we dig deeper, there’s often something living in them. An unresolved H. pylori. Elevated CMV titers. Mycotoxins in their urine from a building they lived in years ago.

Most aging models ignore this entirely. They assume the body deteriorates in isolation — cells accumulate damage, telomeres shorten, inflammation builds up from within. That model is incomplete.

What research published in 2024 and 2025 now shows clearly: many chronic pathogens don’t just make you sick. They actively reprogram your cells to age faster.

Pathogens induce cellular senescence — on purpose

Cellular senescence is when a cell stops dividing but doesn’t die. It sits there, releasing inflammatory signals (called the SASP — Senescence-Associated Secretory Phenotype) that damage surrounding tissue. Normally, senescent cells are a protective response to DNA damage. The problem is that many chronic pathogens deliberately trigger this state in your cells to survive.

A 2025 paper in Immunity & Ageing laid out the mechanism directly: pathogens exploit cellular senescence to create a stable niche inside the host. By driving your cells into senescence, they suppress immune clearance, reduce cell turnover, and establish long-term residence. The result for you is accelerated biological aging across multiple organ systems.

Key finding: Tuberculosis infection accelerates biological (epigenetic) age by an average of 12–14 years in infected patients — measured by DNA methylation clocks, not questionnaires. Patients show elevated levels of TNF-α, CXCL9, and CXCL10, the same SASP proteins seen in accelerated aging from other causes. Source: PMC10518457

The specific pathogens that age you most

Not all infections carry the same aging burden. These are the ones with the most evidence for long-term cellular damage:

H. pylori (bacteria)

Shortens telomeres in gastric epithelial cells, activates NF-κB chronically, raises IL-6 and IL-8. Present in ~44% of the global population — most never know.

CMV (herpesvirus)

Cytomegalovirus drives immune senescence — filling up your T-cell repertoire with CMV-specific cells until there’s little room for anything else. Affects 50–80% of adults over 40.

Candida / systemic fungi

Chronic low-grade fungal overgrowth drives gut permeability and systemic inflammation. Harder to detect without targeted testing. Often linked to recurrent fatigue and brain fog.

Lyme / Borrelia

Significant increase in senescence markers (SA-β-Gal) in serum of Lyme patients vs. healthy controls. Creates an inflammaging state that persists long after antibiotic treatment.

What this means for symptoms you’ve normalized

This is the part that matters clinically. Chronic low-grade infection looks like ordinary aging. Persistent fatigue. Brain fog that comes and goes. Joints that ache without clear cause. Immune response that feels slower than it used to. Many patients have been told these are “just aging” when they’re actually driven by an identifiable, treatable pathogen.

I’ve seen this enough times in practice to take it seriously: patients in their 50s and 60s with these symptoms who turn out to have unresolved H. pylori, elevated CMV antibody titers, or chronic mycotoxin exposure. Treating the underlying infection doesn’t just relieve the immediate symptoms — it changes the trajectory of their cellular aging.

The inflammation link: why “inflammaging” has a pathogen component

The term “inflammaging” describes the chronic low-grade inflammation that drives most age-related diseases — cardiovascular disease, neurodegeneration, cancer, metabolic syndrome. What’s increasingly clear is that a significant fraction of this inflammaging is pathogen-driven.

The SASP cytokines released by senescent cells infected with chronic pathogens are the same ones that drive atherosclerosis, insulin resistance, and neuroinflammation. Alzheimer’s amyloid-β — the plaque that defines the disease — has been shown to function as an antimicrobial peptide: it forms in the brain specifically as a response to infection. The leading question in Alzheimer’s research is no longer whether infection plays a role. It’s which pathogens, in which patients.

What we test for at Long Life Clinic

Standard checkups don’t screen for chronic infectious burden. A full longevity workup should include:

• H. pylori: Breath test or stool antigen — not just antibodies (which stay positive after eradication)
• CMV IgG avidity + viral load: High avidity = past infection; active replication = ongoing immune burden
• Mycotoxins in urine: If there’s a history of water-damaged buildings, chronic fatigue, or brain fog
• Heavy metals: Often co-exist with chronic infection and compound the oxidative stress
• Inflammatory markers: hsCRP, IL-6, TNF-α — indirect but useful for tracking total burden

The intervention priority

If you find active H. pylori — treat it. The standard triple therapy is effective and the benefits for gastric cancer prevention alone are worth it. CMV has no curative treatment but its immune burden can be managed by keeping the rest of your immune system strong — adequate sleep, exercise, and avoiding immunosuppression.

For fungal overgrowth, the intervention is dietary first (reduce refined sugar and alcohol), then targeted antifungal protocols if testing confirms systemic involvement.

The broader point: infection is a modifiable driver of aging. It belongs in the same conversation as hormones, sleep, and metabolic health — not as a separate medical specialty, but as part of a unified longevity assessment.

References: Viral & bacterial infections → senescence (PMC10518457) · Pathogens accelerate human aging features (PMID 40783071) · Chronic infections & cellular senescence (PMID 41074202) · Impacts of chronic infections on senescence — Immunity & Ageing 2025